Cargando…

Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis

OBJECTIVE: COVID-19, coinciding with the opioid epidemic in the United States, has had significant impacts on health-care utilization. While mixed, early analyses signaled a potential resurgence in opioid use following the pandemic. The primary study objective was to assess the association of the CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Heather D, Patterson, Vanessa Paul, Wright, Garth, Rawlings, Julia E, Moore, Gina D, Leonard, Jim, Page II, Robert L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516188/
https://www.ncbi.nlm.nih.gov/pubmed/37744558
http://dx.doi.org/10.2147/TCRM.S424961
_version_ 1785109086439735296
author Anderson, Heather D
Patterson, Vanessa Paul
Wright, Garth
Rawlings, Julia E
Moore, Gina D
Leonard, Jim
Page II, Robert L
author_facet Anderson, Heather D
Patterson, Vanessa Paul
Wright, Garth
Rawlings, Julia E
Moore, Gina D
Leonard, Jim
Page II, Robert L
author_sort Anderson, Heather D
collection PubMed
description OBJECTIVE: COVID-19, coinciding with the opioid epidemic in the United States, has had significant impacts on health-care utilization. While mixed, early analyses signaled a potential resurgence in opioid use following the pandemic. The primary study objective was to assess the association of the COVID-19 pandemic with opioid utilization among Health First Colorado (Colorado’s Medicaid Program) members and a non-Medicaid managed care cohort who did not have a diagnosis of cancer or sickle cell disease. PATIENTS AND METHODS: Using an interrupted time series and segmented regression analysis, this population-level study assessed the association of the COVID-19 pandemic on prescribed utilization of long- and short-acting opioid analgesics among Health First Colorado members and a random sample of non-Medicaid managed care members. Pharmacy claims data for both cohorts were assessed between October 1, 2018, and September 30, 2021, with April 2020 identified as the interruption of interest. We evaluated the following monthly opioid use measures separately for short-acting and long-acting opioids: number of members filling an opioid, total fills, and total days supplied. RESULTS: Short- and long-acting opioid utilization was significantly decreasing among Health First Colorado members in the 18 months prior to the start of COVID-19. After the onset of the pandemic, utilization stabilized and slopes were not significantly different from zero. Among the non-Medicaid managed care cohort, short- and long-acting opioid utilization significantly decreased in the 18 months leading up to the onset of the pandemic. After the onset of the pandemic, utilization of long-acting opioids stabilized, while utilization of short-acting opioids significantly increased. CONCLUSION: While we observed an increase in opioid utilization measures post-pandemic in the non-Medicaid managed care cohort, a similar increase was not observed in Health First Colorado members suggesting that thoughtful opioid policies put in place pre-pandemic may have been effective at controlling potential inappropriate opioid utilization.
format Online
Article
Text
id pubmed-10516188
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105161882023-09-23 Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis Anderson, Heather D Patterson, Vanessa Paul Wright, Garth Rawlings, Julia E Moore, Gina D Leonard, Jim Page II, Robert L Ther Clin Risk Manag Original Research OBJECTIVE: COVID-19, coinciding with the opioid epidemic in the United States, has had significant impacts on health-care utilization. While mixed, early analyses signaled a potential resurgence in opioid use following the pandemic. The primary study objective was to assess the association of the COVID-19 pandemic with opioid utilization among Health First Colorado (Colorado’s Medicaid Program) members and a non-Medicaid managed care cohort who did not have a diagnosis of cancer or sickle cell disease. PATIENTS AND METHODS: Using an interrupted time series and segmented regression analysis, this population-level study assessed the association of the COVID-19 pandemic on prescribed utilization of long- and short-acting opioid analgesics among Health First Colorado members and a random sample of non-Medicaid managed care members. Pharmacy claims data for both cohorts were assessed between October 1, 2018, and September 30, 2021, with April 2020 identified as the interruption of interest. We evaluated the following monthly opioid use measures separately for short-acting and long-acting opioids: number of members filling an opioid, total fills, and total days supplied. RESULTS: Short- and long-acting opioid utilization was significantly decreasing among Health First Colorado members in the 18 months prior to the start of COVID-19. After the onset of the pandemic, utilization stabilized and slopes were not significantly different from zero. Among the non-Medicaid managed care cohort, short- and long-acting opioid utilization significantly decreased in the 18 months leading up to the onset of the pandemic. After the onset of the pandemic, utilization of long-acting opioids stabilized, while utilization of short-acting opioids significantly increased. CONCLUSION: While we observed an increase in opioid utilization measures post-pandemic in the non-Medicaid managed care cohort, a similar increase was not observed in Health First Colorado members suggesting that thoughtful opioid policies put in place pre-pandemic may have been effective at controlling potential inappropriate opioid utilization. Dove 2023-09-18 /pmc/articles/PMC10516188/ /pubmed/37744558 http://dx.doi.org/10.2147/TCRM.S424961 Text en © 2023 Anderson et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Anderson, Heather D
Patterson, Vanessa Paul
Wright, Garth
Rawlings, Julia E
Moore, Gina D
Leonard, Jim
Page II, Robert L
Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title_full Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title_fullStr Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title_full_unstemmed Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title_short Evaluating the Effect of COVID-19 on Outpatient Opioid Utilization Among Health First Colorado Members and a National Non-Medicaid Cohort: An Interrupted Time Series Analysis
title_sort evaluating the effect of covid-19 on outpatient opioid utilization among health first colorado members and a national non-medicaid cohort: an interrupted time series analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516188/
https://www.ncbi.nlm.nih.gov/pubmed/37744558
http://dx.doi.org/10.2147/TCRM.S424961
work_keys_str_mv AT andersonheatherd evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT pattersonvanessapaul evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT wrightgarth evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT rawlingsjuliae evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT mooreginad evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT leonardjim evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis
AT pageiirobertl evaluatingtheeffectofcovid19onoutpatientopioidutilizationamonghealthfirstcoloradomembersandanationalnonmedicaidcohortaninterruptedtimeseriesanalysis